L

LAVA Therapeutics NV
D

LVTX

1.86000
USD
-0.04
(-2.11%)
Market Closed
Volume
527
EPS
0
Div Yield
0
P/E
-2
Market Cap
48,913,019
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    2.78
    (0.84%)
    335.22 USD
    B
    BIIB
    -2.500
    (-1.17%)
    210.710 USD
    B
    BMRN
    0.270
    (0.32%)
    84.620 USD
    GILD
    0.470
    (0.62%)
    76.510 USD
    I
    ILMN
    -0.250
    (-0.20%)
    122.370 USD
    I
    INCY
    -0.680
    (-1.05%)
    64.390 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
    VRTX
    9.75
    (1.97%)
    505.40 USD
    More
News

Title: LAVA Therapeutics NV

Sector: Healthcare
Industry: Biotechnology
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigenfor the treatment of cancer.